Abstract
BackgroundInterstitial lung disease (ILD) is one of the leading causes of mortality in patients with systemic sclerosis (SSc). Serum biomarkers have been suggested as indicators for pulmonary damage with clinical...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have